We found 84% of cancer patients taking ivermectin + mebendazole declared their cancer had COMPLETELY DISAPPEARED, SHRUNK, or STOPPED SPREADING after 6 months.
We found 84% of cancer patients taking ivermectin + mebendazole declared their cancer had COMPLETELY DISAPPEARED, SHRUNK, or STOPPED SPREADING after 6 months. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. pic.twitter.com/ozCaoNvKVh — Nicolas Hulscher, MPH (@NicHulscher) August 16, 2026